[1] Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts. Int J Stroke 2016;11:6–18.
[2] Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011;6:47–59. https://doi.org/10.1111/j.1747-4949.2010.00552.x.
[3] Prins ND, Scheltens P. White Matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurosci 2015;11:157–65. https://doi.org/10.1038/nrneurol.2015.10.
[4] Benjamin P, Lawrence AJ, Lambert C, Patel B, Chung AW, MacKinnon AD, et al. Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease. NeuroImage Clin 2014;4:828–37.
[5] De Guio F, Duering M, Fazekas F, De Leeuw F-E, Greenberg SM, Pantoni L, et al. Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative. J Cereb Blood Flow Metab 2020;40:231–45.
[6] Charidimou A, Werring DJ. Cerebral microbleeds and cognition in cerebrovascular disease : An update. J Neurol Sci 2012;322:50–5.
[7] Prins ND, Dijk EJ Van, Heijer T Den, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed , executive function and memory. Brain 2005;128:2034–41. https://doi.org/10.1093/brain/awh553.
[8] Raja R, Rosenberg G, Caprihan A. Review of diffusion MRI studies in chronic white matter diseases. Neurosci Lett 2019;694:198–207.
[9] Lyoubi-Idrissi AL, Jouvent E, Poupon C, Chabriat H. Diffusion magnetic resonance imaging in cerebral small vessel disease. Rev Neurol (Paris) 2017;173:201–10. https://doi.org/10.1016/j.neurol.2017.03.005.
[10] Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, et al. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms. Ann Neurol 2016;80:581–92. https://doi.org/10.1002/ana.24758.
[11] Zeestraten EA, Benjamin P, Lambert C, Lawrence AJ, Williams OA, Morris RG, et al. Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease. PLoS One 2016;11:1–16. https://doi.org/10.1371/journal.pone.0147836.
[12] Zeestraten EA, Lawrence AJ, Lambert C, Benjamin P, Brookes RL, Mackinnon AD, et al. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease. Neurology 2017;89:10–1212. https://doi.org/10.1212/WNL.0000000000004594.
[13] Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: Its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999–2005.
[14] Croall ID, Lohner V, Moynihan B, Khan U, Hassan A, O’Brien JT, et al. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies. Clin Sci 2017;131:1361–73. https://doi.org/10.1042/CS20170146.
[15] Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505.
[16] Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR, et al. Mechanisms of Cognitive Impairment in Cerebral Small Vessel Disease: Multimodal MRI Results from the St George’s Cognition and Neuroimaging in Stroke (SCANS) Study. PLoS One 2013;8.
[17] Vinciguerra C, Giorgio A, Zhang J, Donato I Di, Stromillo ML, Brocci RT, et al. Peak width of skeletonized mean di ff usivity ( PSMD ) as marker of widespread white matter tissue damage in multiple sclerosis ☆. Mult Scler Relat Disord 2019;27:294–7. https://doi.org/10.1016/j.msard.2018.11.011.
[18] Mccreary CR, Beaudin AE, Subotic A, Zwiers AM, Alvarez A, Charlton A, et al. NeuroImage : Clinical Cross-sectional and longitudinal differences in peak skeletonized white matter mean di ff usivity in cerebral amyloid angiopathy. NeuroImage Clin 2020;27:102280. https://doi.org/10.1016/j.nicl.2020.102280.
[19] Duering M, Finsterwalder S, Baykara E, Tuladhar AM, Gesierich B, Konieczny MJ, et al. Free water determines diffusion alterations and clinical status in cerebral small vessel disease. J Autism Dev Disord 2017;47:549–62. https://doi.org/10.1016/j.jalz.2017.12.007.
[20] Konieczny MJ, Dewenter A, Ter Telgte A, Gesierich B, Wiegertjes K, Finsterwalder S, et al. Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel Disease. vol. 96. 2021. https://doi.org/10.1212/WNL.0000000000011213.
[21] Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman R a., Hurting H, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am Roentgen Ray Soc 1987;149:351–6. https://doi.org/10.2214/ajr.149.2.351.
[22] Fernandes S. Teste de Cores e Palavras de Stroop. Lisboa: CEGOC-TEA; 2013.
[23] Cavaco S, Gonçalves A, Pinto C, Almeida E, Gomes F, Moreira I, et al. Trail making test: Regression- based norms for the portuguese population. Arch Clin Neuropsychol 2013;28:189–98.
[24] O’Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SCR, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441–7.
[25] O’Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005;65:1584–90.
[26] Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:S208–19.
[27] Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57.
[28] Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22.
[29] Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56.
[30] Jenkinson M, Bannister P, Brady M, Smith S. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images. Neuroimage 2002;17:825–41. https://doi.org/10.1006/nimg.2002.1132.
[31] S.M. G, U.J. C, M.M. B, T.A. Y, C. K, H.R. J, et al. The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology 2009;73:1759–66. https://doi.org/10.1212/WNL.0b013e3181c34a7d.
[32] Wardlaw JM. What Is a Lacune? Stroke 2008;39:2921–2.
[33] Andersson JLRR, Sotiropoulos SN. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 2016;125:1063–78. https://doi.org/10.1016/j.neuroimage.2015.10.019.
[34] Andersson JLRR, Graham MS, Zsoldos E, Sotiropoulos SN. Incorporating outlier detection and replacement into a non-parametric framework for movement and distortion correction of diffusion MR images. Neuroimage 2016;141:556–72. https://doi.org/10.1016/j.neuroimage.2016.06.058.
[35] Behrens TEJ, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003;50:1077–88.
[36] Behrens TEJ, Berg HJ, Jbabdi S, Rushworth MFS, Woolrich MW. Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage 2007;34:144–55.
[37] Grabner G, Janke AL, Budge MM, Smith D, Pruessner J, Collins DL. Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. Med Image Comput Comput Assist Interv, vol. 9, 2006, p. 58–66. https://doi.org/10.1007/11866763_8.
[38] Tuladhar AM, van Norden AGW, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, et al. White matter integrity in small vessel disease is related to cognition. NeuroImage Clin 2015;7:518–24.
[39] Freedman D, Diaconis P. On the histogram as a density estimator:L 2 theory. Zeitschrift Für Wahrscheinlichkeitstheorie Und Verwandte Gebiete 1981;57:453–76. https://doi.org/10.1007/BF01025868.
[40] Metzler-Baddeley C, O’sullivan MJ, Bells S, Pasternak O, Jones DK. How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 2012;59:1394–403. https://doi.org/10.1016/j.neuroimage.2011.08.043.
[41] Williams OA, Zeestraten EA, Benjamin P, Lambert C, Lawrence AJ, Mackinnon AD, et al. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change. NeuroImage Clin 2017;16:330–42. https://doi.org/10.1016/j.nicl.2017.08.016.
[42] Andersson JLRR, Skare S, Ashburner J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 2003;20:870–88. https://doi.org/10.1016/S1053-8119(03)00336-7.
[43] Cheng J, Shen D, Yap PT, Basser PJ. Single- and Multiple-Shell Uniform Sampling Schemes for Diffusion MRI Using Spherical Codes. IEEE Trans Med Imaging 2018;37:185–99. https://doi.org/10.1109/TMI.2017.2756072.